open access

Vol 15, No 2 (2012)
Original articles
Published online: 2012-08-27
Submitted: 2012-08-31
Accepted: 2012-08-31
Get Citation

Localisation of sentinel lymph nodes in patients with melanomas by planar lymphoscintigraphic and hybrid SPECT/CT imaging

Otakar Kraft, Martin Havel
Nucl. Med. Rev 2012;15(2):101-107.

open access

Vol 15, No 2 (2012)
Original articles
Published online: 2012-08-27
Submitted: 2012-08-31
Accepted: 2012-08-31

Abstract

BACKGROUND: The aim of the study was to assess the role of
planar lymphoscintigraphy and fusion imaging of SPECT/CT in sentinel
lymph node (SLN) identification in patients with melanomas.


MATERIAL AND METHODS: Planar and hybrid SPECT/low-dose
CT lymphoscintigraphy were performed in 113 consecutive patients
with melanomas (59 men, 54 women, mean age 57.6 with
range 11–87 years, BMI 29.4 ± 12.5). The radiopharmaceutical
was injected around the tumour (Group A, 59 patients), or
around the scar (Group B, 54 patients). Localisation of melanomas:
head and neck 4, trunk 55, upper extremities 28, lower
extremities 26. Planar and SPECT/CT images were interpreted
separately by two nuclear medicine physicians. Abilities of these
two techniques to image SLN were compared.


RESULTS: SLNs were detected on lymphoscintigraphy comprising
planar and SPECT-CT images in 108 (95.6%) study patients;
there was failure to detect SLNs in the remaining 5 (4.4%) patients. Planar images identified 253 SLNs in 100 (88.5%) pts,
with a mean of 2.2 ± 1.7 (range 0–9 nodes) per patient. In the
remaining 13 (11.5%) patients no SLNs were detected on planar
images. On SPECT-CT images, 334 hot nodes were detected
in 107 (94.7%) patients with a mean of 3.0 ± 2.1 (range 0–9)
nodes per patient. In the remaining 6 (5.3%) patients, SPECT-CT
was negative.
SPECT/CT visualised lymphatic drainage in 8 (7.1%) patients
with non-visualisation on planar imaging.


CONCLUSIONS: In some patients with melanomas SPECT/CT
improves detection of sentinel lymph nodes. It can image nodes
not visible on planar scintigrams, exclude false positive uptake
and exactly localize SLNs.

Abstract

BACKGROUND: The aim of the study was to assess the role of
planar lymphoscintigraphy and fusion imaging of SPECT/CT in sentinel
lymph node (SLN) identification in patients with melanomas.


MATERIAL AND METHODS: Planar and hybrid SPECT/low-dose
CT lymphoscintigraphy were performed in 113 consecutive patients
with melanomas (59 men, 54 women, mean age 57.6 with
range 11–87 years, BMI 29.4 ± 12.5). The radiopharmaceutical
was injected around the tumour (Group A, 59 patients), or
around the scar (Group B, 54 patients). Localisation of melanomas:
head and neck 4, trunk 55, upper extremities 28, lower
extremities 26. Planar and SPECT/CT images were interpreted
separately by two nuclear medicine physicians. Abilities of these
two techniques to image SLN were compared.


RESULTS: SLNs were detected on lymphoscintigraphy comprising
planar and SPECT-CT images in 108 (95.6%) study patients;
there was failure to detect SLNs in the remaining 5 (4.4%) patients. Planar images identified 253 SLNs in 100 (88.5%) pts,
with a mean of 2.2 ± 1.7 (range 0–9 nodes) per patient. In the
remaining 13 (11.5%) patients no SLNs were detected on planar
images. On SPECT-CT images, 334 hot nodes were detected
in 107 (94.7%) patients with a mean of 3.0 ± 2.1 (range 0–9)
nodes per patient. In the remaining 6 (5.3%) patients, SPECT-CT
was negative.
SPECT/CT visualised lymphatic drainage in 8 (7.1%) patients
with non-visualisation on planar imaging.


CONCLUSIONS: In some patients with melanomas SPECT/CT
improves detection of sentinel lymph nodes. It can image nodes
not visible on planar scintigrams, exclude false positive uptake
and exactly localize SLNs.

Get Citation

Keywords

sentinel node, malignant melanoma, lymphoscintigraphy, planar scintigraphy, SPECT/CT

About this article
Title

Localisation of sentinel lymph nodes in patients with melanomas by planar lymphoscintigraphic and hybrid SPECT/CT imaging

Journal

Nuclear Medicine Review

Issue

Vol 15, No 2 (2012)

Pages

101-107

Published online

2012-08-27

Bibliographic record

Nucl. Med. Rev 2012;15(2):101-107.

Keywords

sentinel node
malignant melanoma
lymphoscintigraphy
planar scintigraphy
SPECT/CT

Authors

Otakar Kraft
Martin Havel

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., Świętokrzyska 73 street, 80–180 Gdańsk, Poland

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl